徐沪济 - 清华大学

个人简介

徐沪济教授是清华大学临床医学院常务副院长、清华大学临床医学学术委员会主席、清华北大生命科学中心研究员，现任海军军医大学长征医院大内科主任和风湿免疫科主任。学术荣誉与奖励 2019 上海科技进步奖一等奖（第一完成人） 2019 享受国务院特殊津贴 2014 科技部973计划项目“首席科学家” 2013 上海医学科技奖一等奖（第一完成人） 2012 海外高层次人才“国家特聘专家” 2011 个人“二等功”一次 2012 军队“科技金星”待遇专家 2010 上海市“领军人才” 2008 上海市“优秀学科带头人” 开设课程自身免疫病的基础理论和临床实践临床免疫进展其他社会职务中国人民解放军免疫学专业委员会副主任委员中国医师协会风湿免疫科医师分会委员会副会长《Annals of Rheumatic Diseases》编委《Frontiers in Immunology》副主编《Frontiers in Medicine》副主编《中国内科年鉴》主编中华医学会风湿病学分会第九届委员会副主任委员上海市医学会风湿病专科分会主任委员《Nature Review of Rheumatology》中文版主编《Frontier in Microbiology and Immunology》编委《Rheumatology (Oxford)》编委

研究领域

开展自身免疫和感染免疫疾病研究，发现CD4 T细胞在疟疾感染中的决定性作用, 并最先发现消化道是新冠病毒感染揭示强直性脊柱炎的关键发病机制，为临床诊疗带来实质性改变发现类风湿关节炎新的易感基因，找到候选药物靶点发现CD4 T细胞在疟疾感染中的决定性作用, 并最先发现消化道是新冠病毒感染的重要途径致力于推动我国内科学规范与创新发展第一位担任国际风湿病杂志编委的中国学者，提升我国风湿病研究在国际舞台上的影响力

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Correction: A multi-center, open-label, randomized study to explore efficacy and safety of baricitinib in active primary Sjogren’s syndrome patients (Trials, (2023), 24, 1, (112), 10.1186/s13063-023-07087-5) Bai, W.,?Yang, F.,?Xu, H.,?...Zeng, X.,?Leng, X. Trialsthis link is disabled,?2023, 24(1), 487 MYC promotes fibroblast osteogenesis by regulating ALP and BMP2 to participate in ectopic ossification of ankylosing spondylitis Jin, Q.,?Liu, Y.,?Zhang, Z.,?...Wu, X.,?Xu, H. Arthritis Research and Therapythis link is disabled,?2023, 25(1), 28 A multi-center, open-label, randomized study to explore efficacy and safety of baricitinib in active primary Sjogren’s syndrome patients Bai, W.,?Yang, F.,?Xu, H.,?...Zeng, X.,?Leng, X. Trialsthis link is disabled,?2023, 24(1), 112 The correlations between C-reactive protein and MRI-detected inflammation in patients with axial spondyloarthritis: a systematic review and meta-analysis Tian, H.,?Li, T.,?Wang, Y.,?...Wu, X.,?Xu, H. Clinical Rheumatologythis link is disabled,?2023, 42(9), 页 2397–2407 Identification of potent target and its mechanism of action of Tripterygium wilfordii Hook F in the treatment of lupus nephritis Cai, B.,?Lu, H.,?Ye, Q.,?...Wu, X.,?Xu, H. International Journal of Rheumatic Diseasesthis link is disabled,?2023, 26(8), 页 1529–1539 Engineered protein and Jakinib nanoplatform with extraordinary rheumatoid arthritis treatment Li, Y.,?Li, B.,?Wang, G.,?...Liu, K.,?Xu, H. Nano Researchthis link is disabled,?2023, 16(8), 页 11197–11205 Interactions between host and intestinal crypt-resided biofilms are controlled by epithelial fucosylation Guo, X.-K.,?Wang, J.,?van Hensbergen, V.P.,?...Xu, H.,?Hu, X. Cell Reportsthis link is disabled,?2023, 42(7), 112754 Increased RNA editing sites revealed as potential novel biomarkers for diagnosis in primary Sj?gren's syndrome Wang, X.,?Zhu, L.,?Ying, S.,?...Xu, H.,?Wu, J. Journal of Autoimmunitythis link is disabled,?2023, 138, 103035 Innate and adaptive immune abnormalities underlying autoimmune diseases: the genetic connections Chi, X.,?Huang, M.,?Tu, H.,?...Dong, C.,?Hu, X. Science China Life Sciencesthis link is disabled,?2023, 66(7), 页 1482–1517 Genome-Wide Association Study in Acute Tubulointerstitial Nephritis Zhou, X.-J.,?Su, T.,?Xie, J.,?...Zhang, H.,?Yang, L. Journal of the American Society of Nephrologythis link is disabled,?2023, 34(5), 页 895–908